NasdaqCM - Nasdaq Real Time Price • USD
vTv Therapeutics Inc. (VTVT)
As of 3:12 PM EDT. Market Open.
Major Holders
Breakdown | |
---|---|
54.68% | % of Shares Held by All Insider |
16.06% | % of Shares Held by Institutions |
35.44% | % of Float Held by Institutions |
18 | Number of Institutions Holding Shares |
Top Institutional Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Samsara BioCapital, LLC | 40.89k | Dec 31, 2023 | 1.68% | 1,041,621 |
Vanguard Group Inc | 23.52k | Dec 31, 2023 | 0.97% | 599,146 |
Blackrock Inc. | 1.34k | Dec 31, 2023 | 0.06% | 34,161 |
Tower Research Capital LLC (TRC) | 1.07k | Dec 31, 2023 | 0.04% | 27,258 |
Morgan Stanley | 840 | Dec 31, 2023 | 0.03% | 21,399 |
Royal Bank of Canada | 588 | Dec 31, 2023 | 0.02% | 14,979 |
Focused Wealth Management, Inc | 250 | Dec 31, 2023 | 0.01% | 6,368 |
Osaic Holdings Inc | 50 | Dec 31, 2023 | 0.00% | 1,273 |
Parallel Advisors, LLC | 38 | Dec 31, 2023 | 0.00% | 968 |
Wells Fargo & Company | 30 | Dec 31, 2023 | 0.00% | 764 |
Top Mutual Fund Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Vanguard Total Stock Market Index Fund | 15.63k | Dec 31, 2023 | 0.64% | 398,097 |
Vanguard Extended Market Index Fund | 7.65k | Dec 31, 2023 | 0.31% | 194,985 |
Fidelity Extended Market Index Fund | 2.52k | Feb 29, 2024 | 0.10% | 64,069 |
Fidelity NASDAQ Composite Index Fund | 1.12k | Feb 29, 2024 | 0.05% | 28,506 |
Fidelity Total Market Index Fund | 982 | Feb 29, 2024 | 0.04% | 25,016 |
Fidelity Series Total Market Index Fund | 798 | Feb 29, 2024 | 0.03% | 20,329 |
iShares Core S&P Total U.S. Stock Market ETF | 225 | Feb 29, 2024 | 0.01% | 5,731 |
Related Tickers
XBIO Xenetic Biosciences, Inc.
3.8400
-0.26%
TENX Tenax Therapeutics, Inc.
3.5100
-0.57%
AKTX Akari Therapeutics, Plc
1.1800
-3.28%
VRAX Virax Biolabs Group Limited
0.6636
+0.85%
KRBP Kiromic BioPharma, Inc.
2.9500
+11.74%
HOTH Hoth Therapeutics, Inc.
1.1500
-3.36%
OGEN Oragenics, Inc.
1.0900
0.00%
SEEL Seelos Therapeutics, Inc.
0.3000
-8.28%
NRBO NeuroBo Pharmaceuticals, Inc.
3.0650
+1.49%
CYCC Cyclacel Pharmaceuticals, Inc.
2.2700
+26.82%